secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0001193125-24-144934
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics raises ~$110M via public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 12,743,039 shares of common stock at $5.51/share and pre-funded warrants for 7,220,794 shares at $5.5099 each.
- Gross proceeds estimated at ~$110M; pre-funded warrants are immediately exercisable with no expiration.
- Offering closed on May 22, 2024; underwriters include Jefferies, TD Securities, and Evercore Group.
- Pre-funded warrants include a 9.99% beneficial ownership cap, adjustable to up to 19.99% with 61 days' notice.
- Filing made under effective shelf registration statement (Form S-3, File No. 333-262711).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000119312524144934/0001193125-24-144934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000119312524144934/d822638d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-144934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer